Syed O Hasan
Examiner (ID: 9396, Phone: (571)272-0990 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3783, 3747 |
Total Applications | 907 |
Issued Applications | 710 |
Pending Applications | 53 |
Abandoned Applications | 143 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8406679
[patent_doc_number] => 20120238748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'NOVEL COMPOUNDS HAVING PHENANTHROLINE STRUCTURE'
[patent_app_type] => utility
[patent_app_number] => 13/395906
[patent_app_country] => US
[patent_app_date] => 2010-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11337
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/395906 | Compounds having phenanthroline structure | Sep 12, 2010 | Issued |
Array
(
[id] => 11256784
[patent_doc_number] => 09481675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-01
[patent_title] => 'Gyrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/394985
[patent_app_country] => US
[patent_app_date] => 2010-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24365
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394985
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/394985 | Gyrase inhibitors | Sep 9, 2010 | Issued |
Array
(
[id] => 9762378
[patent_doc_number] => 08846702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators'
[patent_app_type] => utility
[patent_app_number] => 13/392647
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32143
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392647 | Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators | Aug 25, 2010 | Issued |
Array
(
[id] => 8371396
[patent_doc_number] => 20120220785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'SULTONE COMPOUND DERIVATIVES SUBSTITUTED BY NUCLEOPHILES, IN PARTICULAR RADIONUCLIDES, AND USE THEREOF FOR MARKING MACROMOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/389837
[patent_app_country] => US
[patent_app_date] => 2010-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389837
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389837 | Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use thereof for marking macromolecules | Aug 9, 2010 | Issued |
Array
(
[id] => 5954201
[patent_doc_number] => 20110034470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Inhibitors of JNK'
[patent_app_type] => utility
[patent_app_number] => 12/852540
[patent_app_country] => US
[patent_app_date] => 2010-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17322
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852540 | Inhibitors of JNK | Aug 8, 2010 | Issued |
Array
(
[id] => 5954303
[patent_doc_number] => 20110034493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'N1-SULFONYL-5-FLUOROPYRIMIDINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/851357
[patent_app_country] => US
[patent_app_date] => 2010-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034493.pdf
[firstpage_image] =>[orig_patent_app_number] => 12851357
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/851357 | N1-sulfonyl-5-fluoropyrimidinone derivatives | Aug 4, 2010 | Issued |
Array
(
[id] => 8199411
[patent_doc_number] => 20120122868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'APAF-1 INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/387240
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16632
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122868.pdf
[firstpage_image] =>[orig_patent_app_number] => 13387240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387240 | Apaf-1 inhibitor compounds | Jul 28, 2010 | Issued |
Array
(
[id] => 8211436
[patent_doc_number] => 20120129868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/387342
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47101
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129868.pdf
[firstpage_image] =>[orig_patent_app_number] => 13387342
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387342 | Poly (ADP-ribose) polymerase (PARP) inhibitors | Jul 28, 2010 | Issued |
Array
(
[id] => 9299850
[patent_doc_number] => 08648078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'PLK inhibitor salts'
[patent_app_type] => utility
[patent_app_number] => 13/387051
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10816
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387051 | PLK inhibitor salts | Jul 21, 2010 | Issued |
Array
(
[id] => 8290441
[patent_doc_number] => 20120178769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'NOVEL COMPOUNDS FOR INHIBITING EEF-2 KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/384398
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6145
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384398
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384398 | NOVEL COMPOUNDS FOR INHIBITING EEF-2 KINASE ACTIVITY | Jul 14, 2010 | Abandoned |
Array
(
[id] => 9582510
[patent_doc_number] => 08772512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Crystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene'
[patent_app_type] => utility
[patent_app_number] => 13/382658
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2719
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382658
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382658 | Crystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene | Jul 7, 2010 | Issued |
Array
(
[id] => 8313856
[patent_doc_number] => 20120190868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM'
[patent_app_type] => utility
[patent_app_number] => 13/382821
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29836
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382821
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382821 | SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM | Jul 7, 2010 | Abandoned |
Array
(
[id] => 8228714
[patent_doc_number] => 20120142923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'MANUFACTURE OF 4-((1R,3S)-6-CHLORO-3-PHENYL-INDAN-1-YL)-1,2,2-TRIMETHYL-PIPERAZINE AND 1-((1R,3S)-6-CHLORO-3-PHENYL-INDAN-1-YL)-3,3-DIMETHYL-PIPERAZINE'
[patent_app_type] => utility
[patent_app_number] => 13/382378
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5664
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382378
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382378 | Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine | Jul 6, 2010 | Issued |
Array
(
[id] => 9245394
[patent_doc_number] => 08609675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Fused Tricyclic Compounds as novel mTOR inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/379685
[patent_app_country] => US
[patent_app_date] => 2010-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34372
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379685 | Fused Tricyclic Compounds as novel mTOR inhibitors | Jun 29, 2010 | Issued |
Array
(
[id] => 8253154
[patent_doc_number] => 20120157481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'TRICYCLIC PYRIMIDINE DERIVATIVES AS WNT ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/380459
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17498
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157481.pdf
[firstpage_image] =>[orig_patent_app_number] => 13380459
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/380459 | Tricyclic pyrimidine derivatives as wnt antagonists | Jun 24, 2010 | Issued |
Array
(
[id] => 6617476
[patent_doc_number] => 20100324027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/818764
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32933
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818764 | Diazahomoadamantane derivatives and methods of use thereof | Jun 17, 2010 | Issued |
Array
(
[id] => 8708785
[patent_doc_number] => 20130066074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'PROCESS FOR THE PREPARATION OF PROPENAL INTERMEDIATE AND DERIVATIVES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/699569
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5519
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699569 | Process for the preparation of a propenal intermediate and derivatives thereof | Jun 6, 2010 | Issued |
Array
(
[id] => 7712343
[patent_doc_number] => 20120004424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'MICHAEL REACTION WITH RECOVERY OF THE CATALYST'
[patent_app_type] => utility
[patent_app_number] => 12/782706
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 10827
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12782706
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782706 | Michael reaction with recovery of the catalyst | May 17, 2010 | Issued |
Array
(
[id] => 9995934
[patent_doc_number] => 09040531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Alpha helix mimetics and methods relating thereto'
[patent_app_type] => utility
[patent_app_number] => 13/319071
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 51649
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319071 | Alpha helix mimetics and methods relating thereto | May 6, 2010 | Issued |
Array
(
[id] => 9153692
[patent_doc_number] => 08586598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'CDK inhibitor salts'
[patent_app_type] => utility
[patent_app_number] => 13/265918
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11195
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265918
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265918 | CDK inhibitor salts | Apr 22, 2010 | Issued |